More than 80 million people worldwide stutter, roughly 1% of the population, according to the Stuttering Foundation (FAQ, 2024). In the United States, that share holds at more than 3 million Americans (NIDCD, Quick Statistics, 2024). Yet lifetime figures run far higher: a 2025 Nature Genetics analysis counts more than 400 million people affected at some point, because 5% or more of all children pass through a stuttering period, and most recover. This analysis consolidates data from the NIDCD, the Stuttering Foundation, Nature Genetics, the Journal of Fluency Disorders, and 10 other primary sources into one reference on who stutters, who recovers, and what stuttering costs at school and work.
TL;DR
- More than 80 million people worldwide stutter, about 1% of the population (The Stuttering Foundation, FAQ 2024).
- More than 3 million Americans stutter, roughly 1% (NIDCD, Quick Statistics 2024).
- Adult prevalence is 0.96%: 0.63% overt, 0.33% covert (Gattie et al., Journal of Fluency Disorders 2024).
- About 5% of all children go through a stuttering period lasting six months or more (The Stuttering Foundation, Prevalence 2024).
- About 75% of children who stutter recover by late childhood; as many as 1 in 4 continue for life (Stuttering Foundation 2024; NIDCD 2024).
- The adult male-to-female ratio reaches 4 to 1 or larger (Epidemiology of Stuttering review 2013).
- A 2025 genome study of 1M+ people mapped 57 genomic regions across 48 genes (Nature Genetics, Vanderbilt University Medical Center 2025).
- Adults seeking stuttering therapy had a 21.7% social phobia rate versus 1.2% for controls (Iverach et al., Journal of Anxiety Disorders 2009).
- 82% of a UK cohort of 324 children who stutter reported being bullied at school (Teasing and Bullying research, Minnesota State).
- Males who stutter earned $7,627 less per year; matched estimates for women reached $18,712 (Gerlach et al., Journal of Fluency Disorders 2018).
- The global stuttering treatment market reached $2.86 billion in 2026, up 8.9% (The Business Research Company 2026).
1. How Many People Stutter
Prevalence and lifetime incidence are different measures, and conflating them produces the wide range of figures seen online. Point prevalence, the share stuttering right now, sits near 1% of the population, or more than 80 million people worldwide (The Stuttering Foundation). Lifetime figures are far larger because most children who start stuttering recover, so a study can count 400 million people “affected” while only about 1% currently stutter. The most rigorous adult estimate, 0.96%, splits into overt and covert stuttering, a reminder that many adults conceal disfluency.
| Metric | Value | Source |
|---|---|---|
| Americans who stutter | More than 3 million (about 1%) | NIDCD, Quick Statistics (2024) |
| People who stutter worldwide | More than 80 million (~1%) | The Stuttering Foundation, FAQ (2024) |
| Lifetime prevalence, general population | ~5-8% (400M+ ever affected) | Nature Genetics / Vanderbilt (2025) |
| Adult prevalence | 0.96% (0.63% overt, 0.33% covert) | Gattie et al., J. Fluency Disorders (2024) |
| Point prevalence, US children ages 3-17 | 1.60% | Boyle et al. (CDC), Pediatrics (2011) |
| Preschool prevalence, US ages 2-5 | 2.6% | Proctor et al. (2008) |
| Adults engaging with stuttering communities | Fewer than 1% | Gattie et al., J. Fluency Disorders (2024) |
Outlier note: fewer than 1% of adults who stutter engage with stuttering support communities, so surveys recruited through those groups underrepresent the wider population. Stuttering is one strand of a broader picture of voice disorders tracked by the NIDCD.
2. Onset and Recovery in Childhood
Stuttering is overwhelmingly a condition of early childhood, and time is the strongest predictor of outcome. Onset clusters tightly: the average age is about 33 months, and 95% of cases begin by age 4. The reason lifetime incidence dwarfs prevalence is recovery: roughly 75 to 80% of children who begin stuttering stop, most within one to two years. Recovery rates reported across studies range widely because the criteria differ, from self-report to clinician judgment, which is why a 14-year prospective study landed at 65.6% while others exceed 85%.
| Metric | Value | Source |
|---|---|---|
| Children with a stuttering period (6+ months) | About 5% | The Stuttering Foundation, Prevalence (2024) |
| Average age of onset | ~33 months | Epidemiology of Stuttering review (2013) |
| Onsets by age 4 | 95% | Yairi and Ambrose; Epidemiology review (2013) |
| Recover by late childhood | ~75% | The Stuttering Foundation, Prevalence (2024) |
| Recover within 12-24 months, no therapy | 75-80% | The Stuttering Foundation, Prevalence (2024) |
| Continue to stutter for life | As many as 1 in 4 (25%) | NIDCD, Quick Statistics (2024) |
| 14-year prospective recovery rate | 65.6% | J. Fluency Disorders, 14-year follow-up (2024) |
| Children who stutter still stuttering as adults | 3-5% | Univ. of Florida, AJSLP (2024) |
Context note: recovery likelihood drops the longer stuttering persists past onset, which is why early evaluation matters even though most young children recover on their own.
3. Sex Differences, Genetics, and Family History
The widening sex ratio and the strength of family history both point to biology. At onset the male-to-female gap is modest, near 1.6 to 2.2 to 1, then widens to 4 to 1 or larger in adulthood because girls recover at higher rates. Family clustering is well documented: about 60% of people who stutter have a relative who does. The strongest genetic evidence yet came in 2025, when a genome-wide analysis of more than 1 million people identified 57 genomic regions across 48 genes, and found stuttering shares genetic architecture with autism, depression, and musical rhythm (Vanderbilt University Medical Center, in Nature Genetics).
| Metric | Value | Source |
|---|---|---|
| Male-to-female ratio at onset | ~1.6-2.2:1 | Epidemiology of Stuttering review (2013) |
| Male-to-female ratio, adults | 4:1 or larger | Vanderbilt Univ. Medical Center (2025) |
| Heritability (twin studies) | 0.42 to 0.84 | Frigerio-Domingues and Drayna (2017) |
| People who stutter with a relative who stutters | About 60% | The Stuttering Foundation, FAQ (2024) |
| Genome-wide study sample | 1M+ (99,776 cases; 1,023,243 controls) | Nature Genetics / Vanderbilt (2025) |
| Genomic regions linked to stuttering | 57 loci across 48 genes | Nature Genetics / Vanderbilt (2025) |
| US childhood prevalence, Black vs White | 2.63% vs 1.27% | Boyle et al. (CDC), Pediatrics (2011) |
Context note: monozygotic twins show higher concordance than dizygotic twins, but concordance stays below 100%, so genes raise risk without fully determining it.
4. Anxiety, Bullying, and Psychosocial Impact
The social weight of stuttering shows up sharply in the data, and the numbers describe experience rather than a defining trait. Adults seeking stuttering therapy carried a 12-month social phobia rate of 21.7%, versus 1.2% for matched controls, and six to seven times the odds of any anxiety disorder (Iverach et al.). Bullying rates in childhood are strikingly high: in a UK cohort of 324 children who stutter, 82% reported being bullied at some point in school, with 11 to 13 year-olds targeted most. These figures underscore why support, not stigma, drives better outcomes, a theme shared with public speaking anxiety.
| Metric | Value | Source |
|---|---|---|
| 12-month social phobia, adults in therapy | 21.7% (vs 1.2% controls) | Iverach et al., J. Anxiety Disorders (2009) |
| Increased odds of any anxiety disorder | 6 to 7 fold | Iverach et al., J. Anxiety Disorders (2009) |
| Social anxiety disorder, children ages 7-12 | 24% (6x odds of peers) | J. Fluency Disorders, children study (2016) |
| UK children who stutter reporting bullying | 82% (of 324) | Teasing and Bullying research, Minnesota State |
| Children who stutter bullied vs peers | 61% vs 22% | Teasing and Bullying research, Minnesota State |
| Small-sample cohort teased / upset | 57% teased; 81% upset | Teasing and Bullying research, Minnesota State |
| General school victimization rate | 9-35% | Teasing and Bullying research, Minnesota State |
Correction note: the social phobia odds ratios above are matched case-control figures from adults recruited for therapy, who tend toward more severe presentations than the general stuttering population.
5. Workplace and Economic Outcomes
Earnings and employment data show a measurable penalty tied more to bias than to ability. A 2018 study of 13,564 respondents found males who stutter earned $7,627 less and females $7,154 less per year; propensity-matched estimates were larger still, up to $18,712 for women. A 2024 University of Florida study found people who stutter were nearly four times less likely than fluent peers to earn $100,000 or more, and about 25% less likely to report job satisfaction, with dissatisfaction growing over time. The authors point to workplace discrimination, not competence, as a driver of the gap.
| Metric | Value | Source |
|---|---|---|
| Annual earnings gap, males who stutter | $7,627 less | Gerlach et al., J. Fluency Disorders (2018) |
| Annual earnings gap, females who stutter | $7,154 less | Gerlach et al., J. Fluency Disorders (2018) |
| Matched earnings gap, females | $18,712 less | Gerlach et al., J. Fluency Disorders (2018) |
| Females more likely to be underemployed | 23% more likely | Gerlach et al., J. Fluency Disorders (2018) |
| Likelihood of earning $100,000+ | ~4x less likely | Univ. of Florida, AJSLP (2024) |
| Job satisfaction | ~25% less likely to be satisfied | Univ. of Florida, AJSLP (2024) |
| Employment rate, males who stutter | 78% vs 85% | Gerlach et al., J. Fluency Disorders (2018) |
Context note: sample sizes for people who stutter are small in both studies (261 in 2018), so exact dollar figures should be read as directional rather than precise.
6. Treatment, Therapy Outcomes, and Market
Treatment outcomes track closely with age, and the surrounding industry is growing steadily. Early intervention for preschoolers reaches recovery in roughly 75 to 80% of cases, and the RESTART randomized trial found 76.5% of children stutter-free at 18 months with direct treatment. The global stuttering treatment market reached $2.86 billion in 2026, up 8.9% from 2025, and is projected to hit $4.06 billion by 2030 (The Business Research Company). Market estimates diverge sharply by scope, from multi-billion-dollar figures covering therapy services and devices down to roughly $56 million for pharmaceutical therapeutics alone. Speech therapy remains the dominant intervention, alongside feedback devices tracked under AAC and assistive tools.
| Metric | Value | Source |
|---|---|---|
| Preschool early-intervention recovery | 75-80% | Lidcombe / RESTART evidence |
| RESTART: stutter-free at 18 months (direct) | 76.5% (vs 71.4% indirect) | de Sonneville-Koedoot et al., RESTART (2015) |
| Treatment most effective before age | 6 years | German health-insurance data study |
| Global stuttering treatment market, 2025 | $2.62 billion | The Business Research Company (2026) |
| Global stuttering treatment market, 2026 | $2.86 billion (8.9% CAGR) | The Business Research Company (2026) |
| Projected treatment market, 2030 | $4.06 billion (9.2% CAGR) | The Business Research Company (2026) |
| Stuttering therapeutics (pharma), 2035 | $207M (14% CAGR from $56M) | Future Market Insights (2025) |
Divergence note: the $2.62 billion figure covers the full treatment market including services and devices, while the $56 million therapeutics figure counts pharmaceuticals only, which explains the gap rather than a contradiction.
Summary: Stuttering by the Numbers
| Metric | Value | Source |
|---|---|---|
| People who stutter worldwide | More than 80 million (~1%) | The Stuttering Foundation (2024) |
| Americans who stutter | More than 3 million (~1%) | NIDCD (2024) |
| Adult prevalence | 0.96% (0.63% overt, 0.33% covert) | Gattie et al., J. Fluency Disorders (2024) |
| Children with a stuttering period | About 5% | The Stuttering Foundation (2024) |
| Recover by late childhood | ~75% | The Stuttering Foundation (2024) |
| Recover within 12-24 months, no therapy | 75-80% | The Stuttering Foundation (2024) |
| Continue to stutter for life | As many as 1 in 4 | NIDCD (2024) |
| Average age of onset | ~33 months | Epidemiology review (2013) |
| Onsets by age 4 | 95% | Yairi and Ambrose (2013) |
| Male-to-female ratio, adults | 4:1 or larger | Vanderbilt / Nature Genetics (2025) |
| Heritability (twin studies) | 0.42 to 0.84 | Frigerio-Domingues and Drayna (2017) |
| Genome-wide loci identified | 57 across 48 genes | Nature Genetics / Vanderbilt (2025) |
| Genome-wide study sample | 1M+ individuals | Nature Genetics / Vanderbilt (2025) |
| Social phobia, adults in therapy | 21.7% (vs 1.2%) | Iverach et al. (2009) |
| UK children who stutter bullied | 82% (of 324) | Minnesota State research |
| Earnings gap, males who stutter | $7,627 less/yr | Gerlach et al. (2018) |
| Likelihood of earning $100,000+ | ~4x less likely | Univ. of Florida, AJSLP (2024) |
| Global treatment market, 2026 | $2.86 billion | The Business Research Company (2026) |
| Projected treatment market, 2030 | $4.06 billion | The Business Research Company (2026) |
Methodology and Sources
Data was gathered by aggregating figures directly from primary reports, peer-reviewed studies, government statistics pages, and market analyses published or verified during 2025 and 2026, prioritizing original sources over secondary reporting. Every statistic above was read from the cited source, with clinical prevalence studies flagged by year where the most recent canonical data predates 2024.
Sources cited:
- NIDCD (NIH), Quick Statistics About Voice, Speech, Language (2024)
- The Stuttering Foundation, FAQ and Prevalence pages (2024)
- Gattie, Lieven and Kluk, Adult stuttering prevalence I and II, Journal of Fluency Disorders (2024)
- Nature Genetics, Large-scale genome-wide analyses of stuttering (2025), with Vanderbilt University Medical Center summary (2025)
- Yairi and Ambrose, Epidemiology of Stuttering: 21st Century Advances, Journal of Fluency Disorders (2013)
- Boyle et al. (CDC), Trends in the prevalence of developmental disabilities, Pediatrics (2011)
- Iverach et al., Prevalence of anxiety disorders among adults seeking speech therapy for stuttering, Journal of Anxiety Disorders (2009)
- Prevalence of anxiety disorders among children who stutter, Journal of Fluency Disorders (2016)
- Teasing and Bullying of Children Who Stutter, Minnesota State University, Mankato (Blood and Blood; Hugh-Jones and Smith cohorts)
- Gerlach et al., Stuttering and Labor Market Outcomes in the United States, Journal of Fluency Disorders (2018)
- University of Florida, work satisfaction and pay study, American Journal of Speech-Language Pathology (2024)
- Frigerio-Domingues and Drayna, Genetic contributions to stuttering, Molecular Genetics and Genomic Medicine (2017)
- de Sonneville-Koedoot et al., RESTART randomized trial (2015)
- Prevalence and Therapy Rates for Stuttering, Cluttering, and Developmental Speech and Language Disorders, German health-insurance data study (2021)
- The Business Research Company, Stuttering Treatment Global Market Report (2026)
- Future Market Insights, Stuttering Therapeutics Market (2025)
Data watch: The Business Research Company refreshes its stuttering treatment market report annually, with the next edition expected in early 2027; the NIDCD updates its Quick Statistics periodically as new national survey data lands; and the Journal of Fluency Disorders continues to publish adult prevalence and recovery follow-ups, with new longitudinal data likely in the next 12 months. Genome-wide follow-ups building on the 2025 Nature Genetics dataset are also anticipated.
Last updated: July 12, 2026.
We review and update this page quarterly as new data is published.